itm21stadmin

GLP-1 and Beyond: The Evolution of Incretin-Based Therapies for Obesity, Diabetes, and Cardiometabolic Health
Gallery

GLP-1 and Beyond: The Evolution of Incretin-Based Therapies for Obesity, Diabetes, and Cardiometabolic Health

written by Rahul Nawander, MD, FALU, FLMI Introduction Overweight and obesity-related medical costs are estimated at more than $92 billion annually in the U.S. Adults with obesity are associated with an additional $2,505 in annual medical costs that is largely associated with cardiovascular disease (CVD)-related morbidity and mortality. Obesity disproportionately affects minorities with the highest [...]

GLP-1 and Beyond: The Evolution of Incretin-Based Therapies for Obesity, Diabetes, and Cardiometabolic Healthitm21stadmin2025-09-24T13:08:44-04:00

Plasma Cell Disorders
Gallery

Plasma Cell Disorders

written by Rahul Nawander, MD Plasma cell disorders are age-related hematologic conditions that present interpretive challenges for life expectancy underwriting. This article offers a thorough overview of plasma cell disorders, diagnostic criteria, prognostic indicators, treatment options, mortality, and most importantly, underwriting implications. Understanding Plasma Cell Disorders Plasma cells are antibody-producing white blood cells derived from [...]

Plasma Cell Disordersitm21stadmin2025-06-25T14:00:42-04:00

Advancing Frontiers in Metastatic Melanoma: Innovations, Treatments, and Improved Survival Outcomes
Gallery

Advancing Frontiers in Metastatic Melanoma: Innovations, Treatments, and Improved Survival Outcomes

Research by Rahul Nawander, MD, Medical Director at Fasano Underwriting Melanoma of the skin (cutaneous melanoma) is a malignant tumor originating from melanocytes, the skin cells responsible for producing melanin. While primarily occurring in the skin, melanoma can also arise in the eyes, ears, meninges, gastrointestinal tract, and mucosal surfaces such as the oral, [...]

Advancing Frontiers in Metastatic Melanoma: Innovations, Treatments, and Improved Survival Outcomesitm21stadmin2025-01-16T12:01:45-05:00

Life Expectancy in Breast Cancer
Gallery

Life Expectancy in Breast Cancer

By Dr. Rahul Nawander, Fasano Underwriting Medical Director Introduction Breast cancer is a leading cause of morbidity and mortality among women worldwide. In the United States, the American Cancer Society estimates that 310,730 women will be newly diagnosed with breast cancer in 2024, with an estimated 42,250 deaths from the disease [2]. Studies indicate that [...]

Life Expectancy in Breast Canceritm21stadmin2024-09-06T15:24:36-04:00

Falls: Significance in Life Expectancy Underwriting
Gallery

Falls: Significance in Life Expectancy Underwriting

Written by Scott McClure MD As our population ages, the significance and frequency of falls increases. This affects life expectancy as well as morbidity and mortality. It is important to remember this both when evaluating prospective clients in life underwriting and when considering life settlements. In order to begin to understand the significance of falls [...]

Falls: Significance in Life Expectancy Underwritingitm21stadmin2024-08-28T16:13:29-04:00

A New Treatment Protocol for Chronic Pain
Gallery

A New Treatment Protocol for Chronic Pain

by Roger H. Coletti, MD, FACC, FASNC, FSCAI, Medical Director at Fasano Underwriting One of the most common ills of humankind is chronic pain. In some cases, the associated chronic muscle spasm is known to be the culprit. However, in some cases, there is not an obvious connection between the pain and the chronic muscle [...]

A New Treatment Protocol for Chronic Painitm21stadmin2024-06-17T15:54:34-04:00

The Art of Mortality Forecasting
Gallery

The Art of Mortality Forecasting

By John Lynch, Director of Actuarial and Underwriting Services at Longevity Holdings In the realm of underwriting accuracy, mortality outcomes versus predictions fluctuate around average life expectancy, influenced by factors like mortality assumption curves and impairment factors. As population diversifies age, it's crucial to recognize that underwriting status requires continual adaptation. This article explores [...]

The Art of Mortality Forecastingitm21stadmin2024-05-15T14:27:36-04:00

Fred Yang to Cover Primary Election Outlook at Fasano Longevity Conference

What the Polls are Telling Us at Fasano Longevity Conference Hart Research pollster, Fred Yang, will give his analysis of what the polls are telling us about the upcoming Presidential primaries at the November 6th Fasano Longevity Conference. Fred Yang is CEO of Hart Research [...]

Fred Yang to Cover Primary Election Outlook at Fasano Longevity Conferenceitm21stadmin2023-10-31T10:06:55-04:00

How Obesity Impacts Life Expectancy at Fasano Longevity Conference

How Obesity Impacts Life Expectancy at Fasano Longevity Conference Dr. Rahul Nawander will present research on the Impact of Obesity on Mortality and Life Expectancy at the November 6th Fasano Longevity Conference in Washington, DC. Dr. Nawander is Medical Director at Fasano Associates. His presentation will analyze [...]

How Obesity Impacts Life Expectancy at Fasano Longevity Conferenceitm21stadmin2023-10-17T09:40:35-04:00

Impact of Interest Rates on Structured Settlements and Life Settlements at the Fasano Longevity Conference

Impact of Interest Rates on Structured Settlements and Life Settlements at the Fasano Longevity Conference Will Ketterer, Chief Investment Officer of Obra Capital, will analyze the interest rate sensitivity of longevity contingent assets, such as structured settlements and life settlements, at the November 6th Fasano Longevity Conference in Washington, DC. [...]

Impact of Interest Rates on Structured Settlements and Life Settlements at the Fasano Longevity Conferenceitm21stadmin2023-10-10T10:42:10-04:00

About itm21stadmin